Milestones

2019

May
Foundational science behind LifeSprout platform published in Science Translational Medicine.

April
LifeSprout appoints aesthetic industry pioneer Adam Gridley as Executive Chairman of the Board

2018

November
LifeSprout completes GMP production of first injectable products

October
LifeSprout clarifies PMA pathway in pre-IDE meeting with FDA

February
LifeSprout closes Series Seed Financing with major venture capital and strategic leads ($6,500,000)

2017

October
LifeSprout wins Johnson & Johnson QuickFire Device Challenge and AngelMD Sponsorship ($275,000)

September
LifeSprout wins Maryland Stem Cell Research and Commercialization Fund Award ($300,000)

January
Exclusive license secured to foundational intellectual property from Johns Hopkins University

2016

September
Team receives major sponsored research award from the Abell Foundational ($660,000)

July
Team wins translational grant funding from Johns Hopkins and the State of Maryland ($305,000)

2015

September
LifeSprout formed